Business
Currency:USD
2019/FY
Stock NameRevenueRatio
U.S. Lower Extremities & Biologics371.79M40.37%
U.S. Upper Extremities334.5M36.32%
International Extremities & Biologics214.61M23.30%
Region
Currency:USD
2019/FY
Stock NameRevenueRatio
United States706.29M76.70%
Europe, the Middle East, Africa, and Canada154.89M16.82%
Other59.72M6.49%